AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA approves clinical trial to test therapeutic vaccine Collidem.

Vaccine Weekly

| October 08, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 OCT 8 - (NewsRx.com & NewsRx.net) -- IDM (Immuno-Designed Molecules), a biopharmaceutical company in the field of cellular immunotherapy, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to launch a phase I/II clinical trial to test its therapeutic vaccine Collidem for the treatment of colorectal cancer.

Collidem is comprised of the patient's own dendritic cells associated with a combination of selected peptides licensed from Epimmune, Inc. This phase I/II clinical trial will provide the first opportunity to evaluate tolerance, immunologic activity, and clinical response to the vaccine. Thirty-seven patients in the U.S. will be enrolled in the trial, which is expected to take 1 year to complete.

...
Related articles from newspapers, magazines, journals, and more
Eunoe Initiates Alzheimer's Disease Clinical Trial Site In Springfield;...
Press release article from: Business Wire April 29, 2003 700+ words
...Eunoe Inc. today announced the initiation of a clinical trial at Baystate Medical Center in Springfield, Mass. to investigate the use...progression of Alzheimer's disease. "Our first clinical trial showed stabilization of mental function in shunted...
Eunoe Initiates Alzheimer's Disease Clinical Trial; Indiana University Medical...
Press release article from: Business Wire November 13, 2001 700+ words
...initiated a multi-center clinical trial to investigate the...disease. "Our first clinical trial showed stabilization...Indiana University Medical Center, Indianapolis, Ind...Roger Williams Medical Center, Providence, R...
Aastrom Biosciences Expands Bone Graft Clinical Trial to Include Lutheran...
Press release article from: PR Newswire February 17, 2005 700+ words
...Phase I/II clinical trial of its adult...include Lutheran Medical Center in Brooklyn...Lyon at Lutheran Medical Center in Brooklyn...The U.S. clinical trial is being completed...being used in a clinical trial in Spain for...About Lutheran Medical ...
Callisto Pharmaceuticals Clinical Study of Anti-Leukemia Drug L-Annamycin...
Press release article from: Business Wire March 9, 2006 700+ words
...Phase I/IIa clinical trial of L-Annamycin...an additional clinical trial site, the Montefiore Medical Center, Bronx, NY...Montefiore Medical Center is a preeminent...has joined the clinical trial of L-Annamycin...
Geron Reports Presentation of Further Results of Telomerase Cancer Vaccine...
Press release article from: Business Wire December 8, 2003 700+ words
...from a Phase I/II clinical trial of a telomerase therapeutic...at Duke University Medical Center. The results were...investigator on the clinical trial, Johannes Vieweg...the patients in the clinical trial evaluated so far showed...
Aastrom Biosciences expands bone graft clinical trial to include Lutheran...
News wire article from: Asia Africa Intelligence Wire February 17, 2005 700+ words
...the US Phase I/II clinical trial of its adult stem...to include Lutheran Medical Center in Brooklyn, NY...Oak, MI. The US clinical trial is being completed...also being used in a clinical trial in Spain for the treatment...
Geron reports presentation of further results of telomerase cancer vaccine...
News wire article from: Asia Africa Intelligence Wire December 8, 2003 700+ words
...from a Phase I/II clinical trial of a telomerase therapeutic...at Duke University Medical Center. The results were...the patients in the clinical trial evaluated so far showed...observed. The Duke clinical trial uses an ex vivo process...
Callisto Pharmaceuticals clinical study of anti-leukaemia drug L-Annamycin...
News wire article from: Chemical Business Newsbase March 9, 2006 700+ words
...its ongoing Phase I/IIa clinical trial of L-Annamycin to treat...ALL), to an additional clinical trial site, the Montefiore Medical Center, Bronx, NY, a leading...from L-Annamycin. The clinical trial to evaluate L-Annamycin...
ABIOMED Expands AbioCor Clinical Trial Sites to Include University Medical...
Press release article from: Business Wire November 7, 2001 700+ words
...today that University Medical Center, Tucson, AZ and...permission for University Medical Center to participate as...the initial U. S. clinical trial for ABIOMED's AbioCor...The University Medical Center clinical team, led...
TECHNICLONE INTERNATIONAL CORP. REPORTS CLINICAL TRIAL UNDER WAY AT BROTMAN...
Press release article from: PR Newswire May 19, 1992 700+ words
...INTERNATIONAL CORP. REPORTS CLINICAL TRIAL UNDER WAY AT BROTMAN MEDICAL CENTER TUSTIN, Calif...treatment (TNT-1) clinical trial is under way at the Brotman Medical Center, Culver City, Calif. The clinical trial is directed by Drs...
For more facts and information, see all results

Source: HighBeam Research, FDA approves clinical trial to test therapeutic vaccine Collidem.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA